Intra-Cellular Therapies, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2012 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Intra-Cellular Therapies, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2012 to Q2 2024.
  • Intra-Cellular Therapies, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 106M shares, a 9.93% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 106M +9.54M +9.93% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 97.5M +1.8M +1.88% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 96.4M +1.55M +1.64% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 96.2M +1.52M +1.61% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 96.1M +1.72M +1.82% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 95.7M +1.66M +1.77% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 94.8M +12.9M +15.8% Dec 31, 2022 10-K 2024-02-22
Q3 2022 94.7M +13.3M +16.4% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 94.4M +13.1M +16.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 94M +12.9M +15.9% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 81.9M +1.42M +1.77% Dec 31, 2021 10-K 2023-03-01
Q3 2021 81.4M +1.23M +1.54% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 81.3M +25.8M +46.5% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 81.1M +25.6M +46.2% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 80.5M +25M +45% Dec 31, 2020 10-K 2022-03-01
Q3 2020 80.1M +24.9M +45.1% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 55.5M +321K +0.58% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 55.5M +376K +0.68% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 55.5M +612K +1.12% Dec 31, 2019 10-K 2021-02-25
Q3 2019 55.2M +534K +0.98% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 55.2M +486K +0.89% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 55.1M +436K +0.8% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 54.9M +298K +0.55% Dec 31, 2018 10-K 2020-03-02
Q3 2018 54.7M +11.3M +26% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 54.7M +11.3M +26% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 54.7M +11.3M +26% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 54.6M +11.3M +26.1% Dec 31, 2017 10-K 2019-02-27
Q3 2017 43.4M +159K +0.37% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 43.4M +174K +0.4% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 43.4M +183K +0.42% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 43.3M +137K +0.32% Dec 31, 2016 10-K 2018-03-01
Q3 2016 43.3M +258K +0.6% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 43.3M +8.21M +23.4% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 43.2M +8.26M +23.6% Mar 31, 2016 10-Q 2016-04-28
Q4 2015 43.2M +13.7M +46.3% Dec 31, 2015 10-K 2017-03-01
Q3 2015 43M +13.6M +46.3% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 35M +5.7M +19.4% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 35M +5.75M +19.7% Mar 31, 2015 10-Q 2015-04-30
Q4 2014 29.5M +7.34M +33.1% Dec 31, 2014 10-K 2016-02-25
Q3 2014 29.4M +14.8M +101% Sep 30, 2014 10-Q 2014-11-03
Q2 2014 29.3M +24.3M +487% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 29.2M +24.2M +484% Mar 31, 2014 10-Q 2014-05-05
Q4 2013 22.2M +7.56M +51.8% Dec 31, 2013 10-K 2015-03-12
Q3 2013 14.6M Sep 30, 2013 10-Q 2013-11-05
Q2 2013 5M Jun 30, 2013 10-Q 2013-08-15
Q1 2013 5M Mar 31, 2013 10-Q 2013-08-15
Q4 2012 14.6M Dec 31, 2012 10-K 2014-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.